We just received data on a new analyst forecast for $AMLX. James Condulis from Stifel set a price target of 21.0 for AMLX.
To track analyst ratings and price targets for $AMLX, check out Quiver Quantitative's $AMLX forecast page.
Should you buy $AMLX?
Some analysts are better than others. To view the past performance of Stifel, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$AMLX Price Targets
Multiple analysts have issued price targets for $AMLX recently. We have seen 8 analysts offer price targets for $AMLX in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- James Condulis from Stifel set a target price of $21.0 on 03/03/2026
- Geoff Meacham from B of A Securities set a target price of $19.0 on 02/20/2026
- Andrew S. Fein from HC Wainwright & Co. set a target price of $28.0 on 02/10/2026
- Geoff Meacham from Citigroup set a target price of $20.0 on 10/17/2025
- Joel Beatty from Baird set a target price of $19.0 on 10/16/2025
- Corinne Johnson from Goldman Sachs set a target price of $20.0 on 09/16/2025
- Seamus Fernandez from Guggenheim set a target price of $25.0 on 09/15/2025
$AMLX Insider Trading Activity
$AMLX insiders have traded $AMLX stock on the open market 14 times in the past 6 months. Of those trades, 1 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $AMLX stock by insiders over the last 6 months:
- JOSHUA B COHEN (Co-Chief Executive Officer) has made 0 purchases and 4 sales selling 161,382 shares for an estimated $2,191,282.
- JUSTIN B. KLEE (Co-Chief Executive Officer) has made 0 purchases and 4 sales selling 161,403 shares for an estimated $2,190,776.
- KAREN FIRESTONE purchased 8,100 shares for an estimated $100,845
- GINA MAZZARIELLO (Chief Legal Officer) has made 0 purchases and 2 sales selling 6,867 shares for an estimated $98,867.
- CAMILLE L BEDROSIAN (Chief Medical Officer) sold 6,580 shares for an estimated $94,418
- JAMES M FRATES (Chief Financial Officer) has made 0 purchases and 2 sales selling 6,883 shares for an estimated $89,050.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$AMLX Hedge Fund Activity
We have seen 110 institutional investors add shares of $AMLX stock to their portfolio, and 83 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 5,139,212 shares (+45.2%) to their portfolio in Q4 2025, for an estimated $62,081,680
- POINT72 ASSET MANAGEMENT, L.P. removed 2,455,066 shares (-88.0%) from their portfolio in Q4 2025, for an estimated $29,657,197
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 1,983,172 shares (-22.5%) from their portfolio in Q3 2025, for an estimated $26,951,307
- JANUS HENDERSON GROUP PLC added 1,929,639 shares (+76.1%) to their portfolio in Q4 2025, for an estimated $23,310,039
- BLACKROCK, INC. added 1,913,739 shares (+26.8%) to their portfolio in Q4 2025, for an estimated $23,117,967
- PARADIGM BIOCAPITAL ADVISORS LP removed 1,900,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $22,952,000
- COMMODORE CAPITAL LP added 1,574,522 shares (+38.6%) to their portfolio in Q4 2025, for an estimated $19,020,225
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
